Wang H - Search Results

1

Therapeutic efficacy by targeting correction of Notch1-induced aberrants in uveal tumors.

Huang X, Wang L, Zhang H, Wang H, Zhao X, Qian G, Hu J, Ge S, Fan X. Huang X, et al. Among authors: wang h, wang l. PLoS One. 2012;7(8):e44301. doi: 10.1371/journal.pone.0044301. Epub 2012 Aug 28. PLoS One. 2012. PMID: 22937170 Free PMC article.

2

Enhanced therapeutic efficacy by simultaneously targeting two genetic defects in tumors.

Zhang H, Wang H, Zhang J, Qian G, Niu B, Fan X, Lu J, Hoffman AR, Hu JF, Ge S. Zhang H, et al. Among authors: wang h. Mol Ther. 2009 Jan;17(1):57-64. doi: 10.1038/mt.2008.236. Epub 2008 Nov 18. Mol Ther. 2009. PMID: 19018252 Free PMC article.

3

Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block.

Cun B, Song X, Jia R, Zhao X, Wang H, Ge S, Fan X. Cun B, et al. Among authors: wang h. Cancer Biol Ther. 2012 Jan 15;13(2):77-84. doi: 10.4161/cbt.13.2.18436. Cancer Biol Ther. 2012. PMID: 22336909 Free article.

4

Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines.

Huang X, Jia R, Zhao X, Liu B, Wang H, Wang J, Zhou Y, Cun B, Ge S, Fan X. Huang X, et al. Among authors: wang h, wang j. Br J Ophthalmol. 2012 Oct;96(10):1331-8. doi: 10.1136/bjophthalmol-2011-301470. Epub 2012 Jul 27. Br J Ophthalmol. 2012. PMID: 22843987

5

A novel anticancer therapy that simultaneously targets aberrant p53 and Notch activities in tumors.

Yao Y, Wang L, Zhang H, Wang H, Zhao X, Zhang Y, Zhang L, Fan X, Qian G, Hu JF, Ge S. Yao Y, et al. Among authors: wang h, wang l. PLoS One. 2012;7(10):e46627. doi: 10.1371/journal.pone.0046627. Epub 2012 Oct 10. PLoS One. 2012. PMID: 23071601 Free PMC article.

6

Cell growth inhibition in HPV 18 positive uveal melanoma cells by E6/E7 siRNA.

Cun B, Song X, Jia R, Wang H, Zhao X, Liu B, Ge S, Fan X. Cun B, et al. Among authors: wang h. Tumour Biol. 2013 Jun;34(3):1801-6. doi: 10.1007/s13277-013-0719-x. Epub 2013 Mar 14. Tumour Biol. 2013. PMID: 23494180

7

Targeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3'-UTR microRNA.

Zhang J, Huang S, Zhang H, Wang H, Guo H, Qian G, Fan X, Lu J, Hoffman AR, Hu JF, Ge S. Zhang J, et al. Among authors: wang h. Int J Cancer. 2010 May 1;126(9):2229-39. doi: 10.1002/ijc.24821. Int J Cancer. 2010. PMID: 19676053 Free PMC article.

8

Inhibition of retinoblastoma in vitro and in vivo with conditionally replicating oncolytic adenovirus H101.

Song X, Zhou Y, Jia R, Xu X, Wang H, Hu J, Ge S, Fan X. Song X, et al. Among authors: wang h. Invest Ophthalmol Vis Sci. 2010 May;51(5):2626-35. doi: 10.1167/iovs.09-3516. Epub 2009 Dec 10. Invest Ophthalmol Vis Sci. 2010. PMID: 20007825

9

Radiation-inducible human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy: a novel treatment for radioresistant uveal melanoma.

Zhou Y, Song X, Jia R, Wang H, Dai L, Xu X, Gu P, Ge S, Fan X. Zhou Y, et al. Among authors: wang h. Pigment Cell Melanoma Res. 2010 Oct;23(5):661-74. doi: 10.1111/j.1755-148X.2010.00729.x. Epub 2010 Jul 13. Pigment Cell Melanoma Res. 2010. PMID: 20546535

10

Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.

Zhang J, Guo H, Zhang H, Wang H, Qian G, Fan X, Hoffman AR, Hu JF, Ge S. Zhang J, et al. Among authors: wang h. Cancer. 2011 Jan 1;117(1):86-95. doi: 10.1002/cncr.25522. Epub 2010 Aug 24. Cancer. 2011. PMID: 20737575 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150,151 results

Search Page

Filters